Multiple Sclerosis News

August 5, 2016August 5, 2016

Gut Microbiota Is Growing Focus of Multiple Sclerosis Research, Though Treatments Are Few

Multiple Sclerosis News

Gut microbiota (the ecological community of microorganisms that live in the gut) may be an important environmental risk factor for multiple sclerosis (MS). This suggests that strategies to correct ... Read more

June 10, 2016June 16, 2016

Aggressive Stem Cell Therapy Stops MS Relapses, According to Long-term Clinical Trial

Multiple Sclerosis News

Stem cell treatment has been proven to both halt MS clinical relapses and the development of new brain lesions over a prolonged period, according to the results of a ... Read more

May 26, 2016July 4, 2016

MS Australia Puts Out an Owner’s Manual for ‘MS Bike’ and Anyone Willing to Take It for a Spin

Multiple Sclerosis News, News

A bicycle specially designed to mimic the symptoms of multiple sclerosis (MS) now has its own owner’s manual, and the group behind the bike’s creation is inviting anyone interested ... Read more

February 18, 2016May 21, 2018

FDA Grants ‘Breakthrough Therapy’ Designation to Genentech’s Ocrelizumab for PPMS

Multiple Sclerosis News, News, Ocrevus

Genentech recently announced that the U.S. Food and Drug Administration (FDA) granted its investigational medicine ocrelizumab, a potential treatment for primary progressive multiple sclerosis (PPMS), Breakthrough Therapy Designation based on positive Phase 3 ... Read more

January 5, 2016January 5, 2016

Review Highlights Long List of Unmet Needs For MS Patients

Multiple Sclerosis News, News

In a special feature published in the journal American Health & Drug Benefits, authors Stanton R. Mehr, President of SM Health Communications, and Marj P. Zimmerman, President of RxDirections, discuss the ... Read more

December 3, 2015

Coral Gables, FL MS Exchange Event This Saturday To Explore Relapsing MS Management

Multiple Sclerosis News

An interactive event in Coral Gables, FL this weekend will give relapsing Multiple Sclerosis patients who live in the area access to best practices and therapeutic insights that can ... Read more

December 1, 2015March 2, 2016

National Multiple Sclerosis Society Research Milestones

“Learn about the National MS Society‘s research history and how it has dramatically accelerated in the last 5 years. Be part of the solution.” Learn more about MS here: ... Read more

November 19, 2015November 19, 2015

Might Chocolate Ease Multiple Sclerosis Fatigue?

Multiple Sclerosis News, News

A research team from Oxford Brookes University is being given a £70,000 ($107,000) grant to analyze whether dark chocolate can help ease symptoms of multiple sclerosis (MS). The Multiple Sclerosis Society ... Read more

November 13, 2015November 13, 2015

Could Remyelination Be Achieved in MS Using an Anti-Inflammatory Treatment?

Multiple Sclerosis News, News

In a recent study entitled “Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination,” researchers investigated whether sulfasalazine treatment, an anti-inflammatory and immune-modulating drug, could promote remyelination ... Read more

November 10, 2015November 10, 2015

Free MS Exchange Interactive Events Coming to San Antonio and Coral Gables (Miami)

Multiple Sclerosis News, News

Two upcoming, free events for members of the multiple sclerosis community are to be held during the next few weeks at Coral Gables, Florida, and San Antonio, Texas, respectively. ... Read more

November 3, 2015November 3, 2015

Psychiatric Comorbidity Among Multiple Sclerosis Patients Reported to Be Common

Multiple Sclerosis News, News

Psychiatric comorbidity is common in patients with multiple sclerosis (MS), and affects the MS community more frequently than a matched control population, although the incidence is stable over time, according ... Read more

October 23, 2015October 26, 2015

Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe

Multiple Sclerosis News, News

Barcelona, Spain-based, global pharma firm Almirall presented new clinical evidence at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) — held in ... Read more

October 20, 2015October 20, 2015

Generic Form of Glatiramer Acetate Has Equivalent Gene Expression Profile as Teva’s Copaxone

Multiple Sclerosis News, News

In a recent study entitled “Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®,” authors determined potential differences in treatment responses by investigating the gene expression profile of two approved ... Read more

October 15, 2015October 15, 2015

The Future of Stem Cell Therapy for Multiple Sclerosis Patients Relies on Clinical Trial Participation

Multiple Sclerosis News, News

Among the different therapeutic approaches being explored for treating MS, adult stem cell therapy continues to be one of the most discussed and anticipated in the MS community. “Stem cells” — the common ... Read more

October 13, 2015October 13, 2015

Importance of Microbiota in MS Development Explored in ECTRIMS 2015 Presentation

Multiple Sclerosis News, News

Three parallel sessions concerning multiple sclerosis (MS) prevention, clinical phenotypes and magnetic resonance imaging (MRI) were featured at the 31st Congress of the European Committee for Treatment and Research ... Read more

October 12, 2015October 12, 2015

Update on Alemtuzumab (Genzyme’s Lemtrada) Clinical Trial Data Presented at ECTRIMS 2015

Multiple Sclerosis News, News

Multiple Sclerosis News Today recently attended the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) held in Barcelona, Spain, October 7 to 10, 2015. ... Read more

October 9, 2015October 21, 2015

New 3-Times-Per-Week Regimen For Teva’s Copaxone Safe, Effective & Increases Patient Compliance #ECTRIMS2015

Multiple Sclerosis News, News

A Satellite Symposia entitled “Discovering a new world in MS” presented by Teva Neuroscience was held yesterday, October 8 at the 31st Congress of the European Committee for Treatment and ... Read more

October 9, 2015October 9, 2015

Potential MS Drug Cladribine Reported To Have No Impact on Cancer Incidence

Multiple Sclerosis News, News

A new study recently published in the journal Neurology: Neuroimmunology & Neuroinflammation revealed that the drug Cladribine does not increase the risk of cancer in patients with multiple sclerosis ... Read more

October 9, 2015October 9, 2015

Ocrelizumab: Could Genentech/Roche’s Experimental Drug Be the First Effective Progressive MS Therapy?

Multiple Sclerosis News, News

Roche announced positive results for three pivotal Phase III studies of experimental MS therapy ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis (PPMS) patients at this year’s ... Read more

October 8, 2015October 8, 2015

Does Sun Exposure in Early Years Delay MS Onset?

Multiple Sclerosis News, News

Exposure to sunlight may delay the development of multiple sclerosis (MS), according to a new study from researchers in Denmark. The work, titled “Association between age at onset of ... Read more

October 8, 2015October 21, 2015

MS Care: A Hot Topic at #ECTRIMS2015

Multiple Sclerosis News, News

Three “Hot Topic Sessions” on multiple sclerosis will take place this afternoon (17:00 – 17:45 h, GMT + 1h) at the 31st Congress of the European Committee for Treatment ... Read more

October 8, 2015October 21, 2015

Acorda To Present New Data on MS Therapies AMPYRA and Experimental rHIgM22 at #ECTRIMS2015

Multiple Sclerosis News, News

Acorda Therapeutics, Inc., a company focused on therapies for neurological disorders, will present new data on its Phase 1 clinical trial evaluating rHIgM22, and five-year post-marketing safety data on ... Read more

October 5, 2015October 21, 2015

Study Supports High Intensity Exercise to Improve Muscle Condition in MS Patients

Multiple Sclerosis News, News

A new study recently published in the journal PLOS ONE revealed that high intensity exercise is safe and offers clinical benefits for patients with multiple sclerosis (MS). The study ... Read more

October 5, 2015October 5, 2015

Multiple Sclerosis News Today To Provide Live, On-Site Coverage Of 31st Annual #ECTRIMS2015 Congress

Multiple Sclerosis News, News

The 31st meeting of the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (#ECTRIMS2015) is being held this week from October 7 to 10 in Barcelona, ... Read more

September 29, 2015October 21, 2015

Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?

Multiple Sclerosis News, News

Genentech, a leading biotechnology company and member of the Roche Group, recently announced promising results on a pivotal Phase III clinical trial (ORATORIO) assessing its investigational therapy ocrelizumab as a ... Read more

September 24, 2015September 24, 2015

Medical Marijuana Use for Pain Relief in Medical Conditions like MS and AIDS Explored in New Nature Article

Multiple Sclerosis News, News

Cannabis is a plant that can be used in a wide range of settings such as medical purposes, a source of fiber and oils, or as a recreational drug. Growing evidence ... Read more

September 24, 2015September 24, 2015

Brain-specific B Cells’ Reactivity Determines Glatiramer Acetate Therapy Success in MS Patients

Multiple Sclerosis News, News

In a new study entitled “The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients,” a team of scientists discovered that differences in response ... Read more

September 23, 2015September 23, 2015

New Brain Cell Interaction Study Technique Could Impact MS Research

Multiple Sclerosis News, News

A study led by researchers from the University of Buffalo recently reported the development of a new method to study brain cell interaction more precisely. The study, published in the ... Read more

September 22, 2015September 22, 2015

Clinical Benefit of Relapsing-Remitting Multiple Sclerosis Therapies Highlighted in Review

Multiple Sclerosis News, News

A review study recently published in the journal Cochrane Database of Systematic Review (CDSR) focused on the clinical benefit of different therapies available for relapsing-remitting multiple sclerosis (RRMS). The study ... Read more

September 21, 2015September 21, 2015

Fingolimod (Gilenya) Found to Be an Effective Multiple Sclerosis Therapy for Up to Three Years of Treatment

Multiple Sclerosis News, News

An encouraging new analysis reveals that fingolimod is an effective multiple sclerosis (MS) therapy for a treatment period of up to three years. The results were presented at the Annual Meeting of ... Read more

September 18, 2015September 18, 2015

MS Views and News Reaches Two Locations For the First Time in October

Multiple Sclerosis News, News

Non-profit, MS News and Views (MSVN), which works nationally to increase education and knowledge about multiple sclerosis (MS), has announced the organization of two events during the month of October. ... Read more

September 16, 2015September 16, 2015

Aphios Awarded Grant for Cannabinoid Production To Develop Therapeutic Agent for MS

Multiple Sclerosis News, News

Aphios Corporation, a green biotechnology company based in Massachusetts that uses environmentally sustainable technologies, recently announced it was awarded the Phase II portion of a Fast Track SBIR grant from ... Read more

September 15, 2015September 15, 2015

Gut Microbiota Imbalance Discovered in Multiple Sclerosis Patients

Multiple Sclerosis News, News

A new study recently published in the journal PLOS One revealed that multiple sclerosis (MS) patients have a microbial imbalance (dysbiosis) in their gut microbiota that is most likely ... Read more

September 11, 2015September 11, 2015

Melatonin Levels Positively Correlate With Fewer MS Flare-Ups, According to Study

Multiple Sclerosis News, News

Melatonin, the same hormone that helps people fall asleep by regulating the body’s internal clock, may be helpful in treating multiple sclerosis, according to a study from Raúl Carrea ... Read more

September 9, 2015September 9, 2015

Smoking Can Accelerate Disease Progression in Patients with Multiple Sclerosis

Multiple Sclerosis News, News

A new study entitled “Effect of Smoking Cessation on Multiple Sclerosis Prognosis” recently revealed that smoking by patients with multiple sclerosis (MS) post diagnosis accelerates their disease progression course. The ... Read more

September 9, 2015September 9, 2015

Discovery of Mechanism That “Guides” Immune System Cells to Injury Sites Could Benefit MS Research

Multiple Sclerosis News, News

In a new study entitled “Neutrophil trails guide influenza-specific CD8+ T cells in the airways,” researchers uncovered a key mechanism mediated by neutrophils that guides immune system cells to ... Read more

September 8, 2015September 8, 2015

Mental Visual Imagery Strategy Can Improve Neuropsychological Functions in RRMS Patients

Multiple Sclerosis News, News

A new study published in the journal Restorative Neurology and Neuroscience revealed that multiple sclerosis (MS) patients with relapsing-remitting forms of the disease can improve specific neuropsychological functions through ... Read more

September 8, 2015September 8, 2015

New Genetic Risk Factors for Multiple Sclerosis Identified in Study

Multiple Sclerosis News, News

Two new risk factors for multiple sclerosis have been identified by a research group at the Wellcome Trust Centre for Human Genetics at the University of Oxford in the ... Read more

September 7, 2015September 12, 2016

New Study Unravels How Myelin is Repaired, May Suggest New MS Treatments

Multiple Sclerosis News, News

Japanese scientists have discovered new information about how the myelin sheath is repaired following damage. Myelin is a fatty substance that wraps around nerve cells and helps them to conduct ... Read more

September 4, 2015September 4, 2015

Mylan Confirms Continued Patent Proceedings Concerning MS Therapy Copaxone

Multiple Sclerosis News, News

According to a press release from Mylan N.V., the U.S. Patent and Trademark Office (PTO) has issued an inter partes review (IPR) proceeding on all claims against a third Copaxone patent ... Read more